Mayo Clinic deal and $5m funding for health data platform Biofourmis
Singapore-based health analytics platform Biofourmis announced the close of its series A funding round today, while also unveiling a partnership with US medical research institute, the Mayo Clinic. The startup raised US$5 million from NSI Ventures – part of Singaporean private equity firm Northstar Group – and Aviva Ventures, the VC arm of UK insurance company Aviva. Biofourmis will use the series A capital to scale its operations and fund the commercial launch of Biovitals.